Howard Hughes Medical Institute’s Halliburton HAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-182
Closed -$5.14K 235
2025
Q4
$5.14K Sell
182
-2
-1% -$53 ﹤0.01% 336
2025
Q3
$4.53K Sell
184
-3
-2% -$66 ﹤0.01% 362
2025
Q2
$3.81K Buy
+187
New +$3.92K ﹤0.01% 382
2016
Q2
Sell
-9,257
Closed -$331K 170
2016
Q1
$331K Buy
+9,257
New +$302K 0.07% 97
2015
Q4
Sell
-140,000
Closed -$4.95M 179
2015
Q3
$4.95M Hold
140,000
0.93% 19
2015
Q2
$6.03M Buy
+140,000
New +$6.45M 1.28% 13
2014
Q2
Sell
-1,051
Closed -$62K 201
2014
Q1
$62K Buy
+1,051
New +$56.1K 0.01% 144

Other funds holding HAL

Howard Hughes Medical Institute's HAL Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Halliburton (HAL) in Q1 2026, closing a stake of 182 shares — an estimated $5.14K sold.

Howard Hughes Medical Institute first reported a position in HAL in Q1 2014 and held it in 7 quarters. The position peaked at $6.03M in Q2 2015. 1,189 funds tracked by Wall St. Rank hold HAL as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Halliburton position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 182 Halliburton shares in Q1 2026, an estimated $5.14K.
  • Howard Hughes Medical Institute first reported a position in Halliburton in Q1 2014 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Halliburton position peaked at $6.03M in Q2 2015.
  • 1,189 funds tracked by Wall St. Rank held Halliburton as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.